Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anaheal versus diclofenac for pain reduction in temporomandibular joint osteoarthritis
IRCT20241021063454N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in Temporomandibular Osteoarthritis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pain assessment by visual analog scale, Chewing ability and 4 more. Started Nov 2024; status: completed.
02
Drugs
diclofenac
03
Conditions
Temporomandibular Osteoarthritis
Beyond the preview
Go deeper on IRCT20241021063454N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241021063454N1.